| European Case Law Identifier: | ECLI:EP:BA:2019:T084214.20190123 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 23 January 2019 | ||||||||
| Case number: | T 0842/14 | ||||||||
| Application number: | 03767188.0 | ||||||||
| IPC class: | C12Q 1/68 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | IMPROVED COMPOSITIONS FOR IN VITRO AMPLIFICATION OF NUCLEIC ACIDS | ||||||||
| Applicant name: | QIAGEN Beverly, Inc. | ||||||||
| Opponent name: | Zwicker, Jörk | ||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request and auxiliary request 1 - Novelty (no); Auxiliary request 2 - added subject-matter (yes); Auxiliary request 3 - clarity (no); Auxiliary request 4 - sufficiency of disclosure (no); Auxiliary request 5 - admitted into the proceedings (no); Auxiliary request 6 - clarity (no), sufficiency of disclosure (no); |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t140842eu1.html
Date retrieved: 17 May 2021
